Published Online:
February 17, 2010
This Cochrane Review is at the protocol stage and there is no abstract or plain language summary. The objectives for the review are as follows:
This review aims to evaluate the clinical therapeutic efficacy and adverse effects of gemcitabine used as second line chemotherapy for the treatment of recurrent ovarian cancer in women previously treated by surgery and platinum based chemotherapy.